Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 36Neoplasms 8Lung Neoplasms 7Neoplasm Metastasis 4Neoplasms by Site 3Lymphoma, Large-Cell, Anaplastic 3Hematologic Neoplasms 3Breast Neoplasms 3Brain Neoplasms 3Thyroid Neoplasms 2Sarcoma 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Neoplasms by Histologic Type 2Lymphoproliferative Disorders 2Gastrointestinal Neoplasms 2Colorectal Neoplasms 2Carcinoma, Renal Cell 2Urinary Bladder Neoplasms 1Thyroid Cancer, Papillary 1Thoracic Neoplasms 1Solid Tumors 1Sexual Dysfunction, Physiological 1Salivary Gland Neoplasms 1Respiratory Tract Neoplasms 1Respiratory Tract Diseases 1Rare Tumour 1Rare Tumor 1Prostatic Neoplasms 1Neuroendocrine Tumors 1

Interventions

alectinib 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Disease Resistance × alectinib × Clear all
NCT04708639 2021-02-02

MonAlec

Aarhus University Hospital

Unknown
40 enrolled
Thoracic

Lung Neoplasms, Disease Resistance

Data powered by HemOnc (CC BY 4.0) Colophon âš¡